This trial studies how well a web-based eHealth works for genetic counseling compared to the standard genetic counseling provided by a genetic counseling professional in patients with breast cancer that has spread to other places in the body (metastatic) or stage III-IV ovarian cancer. EHealth interventions are a new and efficient delivery model that may increase access and delivery of genetic services while maintaining patient outcomes.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04353973.
PRIMARY OBJECTIVES:
I. To determine if web-based electronic (e)Health delivery of pre-test and/or post-test counseling can provide equal or improved cognitive and affective short-term and 6 month outcomes as compared to the two-visit standard of care delivery model with a genetic counselor.
II. To evaluate patient and delivery factors that moderate the impact of web-based alternatives to genetic counseling on short term and longitudinal cognitive, affective, behavioral outcomes and provider time.
OUTLINE: Patients are randomized to 1 of 4 arms.
ARM A: Patients receive genetic counseling at pre-test and result disclosure sessions.
ARM B: Patients receive genetic counseling at pre-test session and use web-based eHealth tool for at results disclosure session.
ARM C: Patients use web-based eHealth tool at pre-test session and receive genetic counseling session at results disclosure session.
ARM D: Patients use web-based e-Health tool at pre-test and results disclosure sessions.
After completion of study, patients are followed up within 7 days and then at 6 months.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationUniversity of Pennsylvania/Abramson Cancer Center
Principal InvestigatorAngela R. Bradbury
